INDIAN BENCHMARKS are likely to open on a flat note as the global cues look mixed with SGX Nifty trading 2 points lower.Headlines for the day:
Cipla gets USFDA’s tentative approval for HIV drug Kaletra.
Texmaco Rail & engineering reports spectacular numbers.
Natco Pharma posts healthy operating performance.
Trend in FII flows: The FIIs were net buyers of Rs 211.42 Cr in the cash segment on Friday while the DIIs were net buyers of Rs 237.62 Cr, as per the provisional figures released by the NSE.
CapitalStars is a research house and an investment advisory company carrying out operations in the Indian Equities and commodity market. CapitalStras also ave liable on linke din and facebook. Get real time advice for Share Tips , Trading Strategies , Best Intraday Stocks , Stock Tips Free and all market updates. For 2 Days Free Trial ,Please visit our site http://www.capitalstars.com Call at 0731-6790000, 6669900.
0 comments:
Post a Comment